✦ LIBER ✦

Molecular pathology of lung cancer: key to personalized medicine

✍ Scribed by Cheng, Liang; Alexander, Riley E; MacLennan, Gregory T; Cummings, Oscar W; Montironi, Rodolfo; Lopez-Beltran, Antonio; Cramer, Harvey M; Davidson, Darrell D; Zhang, Shaobo

Book ID: 111693866
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 590 KB
Volume: 25
Category: Article
ISSN: 0893-3952
DOI: 10.1038/modpathol.2011.215

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Personalized medicine for lung cancer: n

Personalized medicine for lung cancer: new challenges for pathology

✍ Keith M Kerr 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB

Personalized cancer medicine and the fut

Personalized cancer medicine and the future of pathology

✍ H. Moch; P. R. Blank; M. Dietel; G. Elmberger; K. M. Kerr; J. Palacios; F. Penau 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 239 KB

Gene expression profiling in breast canc

Gene expression profiling in breast cancer: from molecular portraits to personalized medicine

✍ Kornelia Polyak 📂 Article 📅 2004 🏛 Springer Milan 🌐 Spanish ⚖ 166 KB

Genomic medicine in non-small cell lung

Genomic medicine in non-small cell lung cancer: Paving the path to personalized care

✍ Krishna Bajee SRIRAM; Jill Everland LARSEN; Ian Anthony YANG; Rayleen Veronica B 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB

Personalized medicine and development of

Personalized medicine and development of targeted therapies: the upcoming challenge for diagnostic molecular pathology. A review

✍ Manfred Dietel; Christine Sers 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 360 KB

Application of molecular epidemiology to

Application of molecular epidemiology to lung cancer chemoprevention

✍ LaVerne A. Mooney; Frederica P. Perera 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 587 KB

Molecular epidemiology has made great progress in detecting and documenting carcinogenic exposures and host susceptibility factors, in an effort to explain interindividual variation in disease. Interindividual differences in cancer risk have been hypothesized to result from an array of both genetic